117 related articles for article (PubMed ID: 21125547)
1. Vanilloid derivatives as tyrosinase inhibitors driven by virtual screening-based QSAR models.
Rescigno A; Casañola-Martin GM; Sanjust E; Zucca P; Marrero-Ponce Y
Drug Test Anal; 2011 Mar; 3(3):176-81. PubMed ID: 21125547
[TBL] [Abstract][Full Text] [Related]
2. Bond-based 2D quadratic fingerprints in QSAR studies: virtual and in vitro tyrosinase inhibitory activity elucidation.
Casañola-Martin GM; Marrero-Ponce Y; Khan MT; Khan SB; Torrens F; Pérez-Jiménez F; Rescigno A; Abad C
Chem Biol Drug Des; 2010 Dec; 76(6):538-45. PubMed ID: 20964806
[TBL] [Abstract][Full Text] [Related]
3. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
[TBL] [Abstract][Full Text] [Related]
4. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compounds.
Marrero-Ponce Y; Casañola-Martín GM; Khan MT; Torrens F; Rescigno A; Abad C
Curr Pharm Des; 2010; 16(24):2601-24. PubMed ID: 20642427
[TBL] [Abstract][Full Text] [Related]
5. Prediction of tyrosinase inhibition activity using atom-based bilinear indices.
Marrero-Ponce Y; Khan MT; Casañola Martín GM; Ather A; Sultankhodzhaev MN; Torrens F; Rotondo R
ChemMedChem; 2007 Apr; 2(4):449-78. PubMed ID: 17366651
[TBL] [Abstract][Full Text] [Related]
6. Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in 'in silico' selection of new lead tyrosinase inhibitors.
Marrero-Ponce Y; Khan MT; Casañola-Martín GM; Ather A; Sultankhodzhaev MN; García-Domenech R; Torrens F; Rotondo R
J Comput Aided Mol Des; 2007 Apr; 21(4):167-88. PubMed ID: 17333484
[TBL] [Abstract][Full Text] [Related]
7. Novel coumarin-based tyrosinase inhibitors discovered by OECD principles-validated QSAR approach from an enlarged, balanced database.
Le-Thi-Thu H; Casañola-Martín GM; Marrero-Ponce Y; Rescigno A; Saso L; Parmar VS; Torrens F; Abad C
Mol Divers; 2011 May; 15(2):507-20. PubMed ID: 20814821
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors.
Xue CB; Zhang L; Luo WC; Xie XY; Jiang L; Xiao T
Bioorg Med Chem; 2007 Mar; 15(5):2006-15. PubMed ID: 17258462
[TBL] [Abstract][Full Text] [Related]
9. Predictive models for tyrosinase inhibitors: Challenges from heterogeneous activity data determined by different experimental protocols.
Tang H; Cui F; Liu L; Li Y
Comput Biol Chem; 2018 Apr; 73():79-84. PubMed ID: 29471263
[TBL] [Abstract][Full Text] [Related]
10. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
11. Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Khan KM; Torrens F; Rotondo R
Eur J Med Chem; 2007; 42(11-12):1370-81. PubMed ID: 17637486
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 4-hydroxybenzaldehyde derivatives as tyrosinase inhibitors.
Yi W; Cao R; Peng W; Wen H; Yan Q; Zhou B; Ma L; Song H
Eur J Med Chem; 2010 Feb; 45(2):639-46. PubMed ID: 19932528
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors.
Vontzalidou A; Zoidis G; Chaita E; Makropoulou M; Aligiannis N; Lambrinidis G; Mikros E; Skaltsounis AL
Bioorg Med Chem Lett; 2012 Sep; 22(17):5523-6. PubMed ID: 22835872
[TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationship studies of mushroom tyrosinase inhibitors.
Xue CB; Luo WC; Ding Q; Liu SZ; Gao XX
J Comput Aided Mol Des; 2008 May; 22(5):299-309. PubMed ID: 18256890
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of hydroxy- or methoxy-substituted 5-benzylidene(thio) barbiturates as novel tyrosinase inhibitors.
Chen Z; Cai D; Mou D; Yan Q; Sun Y; Pan W; Wan Y; Song H; Yi W
Bioorg Med Chem; 2014 Jul; 22(13):3279-84. PubMed ID: 24857777
[TBL] [Abstract][Full Text] [Related]
16. A turn-on fluorescent probe for detection of tyrosinase activity.
Wang C; Yan S; Huang R; Feng S; Fu B; Weng X; Zhou X
Analyst; 2013 May; 138(10):2825-8. PubMed ID: 23571425
[TBL] [Abstract][Full Text] [Related]
17. Computational strategies towards developing novel antimelanogenic agents.
Unni PA; Lulu SS; Pillai GG
Life Sci; 2020 Jun; 250():117602. PubMed ID: 32240677
[TBL] [Abstract][Full Text] [Related]
18. Kojic acid-amino acid conjugates as tyrosinase inhibitors.
Noh JM; Kwak SY; Seo HS; Seo JH; Kim BG; Lee YS
Bioorg Med Chem Lett; 2009 Oct; 19(19):5586-9. PubMed ID: 19700313
[TBL] [Abstract][Full Text] [Related]
19. In silico modelling of azole derivatives with tyrosinase inhibition ability: Application of the models for activity prediction of new compounds.
De B; Adhikari I; Nandy A; Saha A; Goswami BB
Comput Biol Chem; 2018 Jun; 74():105-114. PubMed ID: 29574329
[TBL] [Abstract][Full Text] [Related]
20. Predicting tyrosinase inhibition by 3D QSAR pharmacophore models and designing potential tyrosinase inhibitors from Traditional Chinese medicine database.
Gao H
Phytomedicine; 2018 Jan; 38():145-157. PubMed ID: 29425647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
